Loading...
Internationally Recognized Certificates of Compliance (IRCC)
  |  
| 
last updated: 16 Aug 2016
General Information
ABSCH-IRCC-IN-207613-1
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113,
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Details of the permit or its equivalent
India/NBA/Appl/9/703

Application in Form-III for seeking approval for the invention " Fed-batch fermentation technique for enhanced production of delta-endotoxin of Bacillus thuringiensis subspecies israelensis" for obtaining IP Rights in India 

06 Jul 2015
Prior Informed Consent (PIC) Information
Yes
- Competent National Authority: | ABSCH-CNA-IN-202013-2
Competent National Authority:
National Biodiversity Authority ()
5th Floor, TICEL Biopark, CSIR Road, Taramani
Chennai, Tamilnadu
600 113,
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Confidential information
- Person: Mr Chengalath Gopinathan | ABSCH-CON-IN-207094-3
Person:
Mr Chengalath Gopinathan
3/1156,sunshine, East hill,
Calicut,
673005,
Phone: +91 495 2381884,
Fax:
Website:
Confidential information
Mutually Agreed Terms (MAT) Information
Yes
1. The user shall notify the NBA on the grant of IPR within 30 days thereof. 
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus government taxes. 
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit the half-yearly report to NBA as per the terms and conditions agreed upon.  

Subject-matter or genetic resource(s)

For obtaining  IP Rights on the Invention " Fed-batch fermentation technique for enhanced producion of delta-endotoxin of Bacillus thuringiensis subspecies israelensis"  in India 

Confidential information
Information on the utilization of the genetic resource(s)
  • Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee. 

 
2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument.   

Additional Information
Amendment history
Unique identifier Status Date
ABSCH-IRCC-IN-207613-1
REVOKED OLD VERSION PUBLISHED DELETED
Sujata Arora (sujata@nic.in)
16 Aug 2016 11:46
on 16 Aug 2016 11:46